The WHO's list of priority medical devices for the treatment of cardiovascular disease and diabetes, released today, will help policy makers and healthcare providers...
INDIANAPOLIS, June 26, 2021 /PRNewswire/ -- Tirzepatide led to superior A1C and body weight reductions from baseline across all three doses in adults with type...